Galantamine for treatment-resistant schizophrenia.
Allen
Trina B
TB
McEvoy
Joseph P
JP
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010277:Parasympathomimetics / Q000627:therapeutic use*; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D005702:Galantamine; D003024:Clozapine; D018967:Risperidone